Each Nitrile Glove offered here is Easy Donning, with Excellent Comfort, High Quality, High Resistance to Tearing, Low Protein, and excellent Fit with Hands.
For large orders, we can bring the cost down to under $0.12 per glove.
We also have different manufacturers of Nitrile Gloves from overseas and US manufacturing partners.
At this price point of $0.14 per Nitrile Glove, the Minimum Order Quantity (MOQ) is 50,000 pieces.
This Nitrile Glove inventory complies with FDA 510K, ISO 9001: 2015, ASTM-D-3578, EN455 PART 1-3, and CE
Beyond the Nitrile Glove products, click here for more Personal Protection Equipment
To order Nirtile Glove boxes, contact: Sales@PPESourceInternational.com
Support Information for Nitrile Glove PPE:
Strategies for Optimizing the Supply of Disposable Medical Gloves
Nitrile Glove info via CDC Source
These considerations are intended for use by federal, state, and local public health officials; leaders in occupational health services and infection prevention and control programs; and other leaders in healthcare settings who are responsible for developing and implementing policies and procedures for preventing pathogen transmission in healthcare settings.
Purpose: This document offers a series of strategies or options to optimize supplies of disposable medical gloves in healthcare settings when there is limited supply. It does not address other aspects of pandemic planning; for those, healthcare facilities can refer to COVID-19 preparedness plans.
Surge capacity refers to the ability to manage a sudden, unexpected increase in patient volume that would otherwise severely challenge or exceed the present capacity of a facility. While there are no widely accepted measurements or triggers to distinguish surge capacity from daily patient care capacity, surge capacity is a useful framework from which to approach a decreased supply of gloves during the COVID-19 response. Three general strata have been used to describe surge capacity and can be used to prioritize measures to conserve glove supplies along the continuum of care.
- Conventional capacity: measures consist of providing patient care without any change in contemporary daily practices. This set of measures, consisting of engineering and administrative controls and personal protective equipment (PPE) should already be implemented in general infection prevention and control plans in healthcare settings.
- Contingency capacity: measures may change daily standard practices but may not have any significant impact on the care delivered to the patient or the safety of healthcare personnel (HCP). These practices may be used temporarily during periods of expected glove shortages.
- Crisis capacity: strategies that are not commensurate with standard U.S. standards of care. These measures, or a combination of these measures, may need to be considered during periods of glove shortages.
The following contingency and crisis strategies are based upon these assumptions:
- Facilities understand their current glove inventory and supply chain.
- Facilities understand their glove utilization rate.
- Facilities are in communication with local healthcare coalitions, federal, state, and local public health partners (e.g., public health emergency preparedness and response staff) regarding identification of additional supplies.
- Facilities have already implemented other engineering and administrative control measures including:
- Reducing the number of patients going to the hospital or outpatient settings
- Excluding HCP not directly involved in patient care
- Reducing face-to-face HCP encounters with patients
- Excluding visitors to patients with confirmed or suspected COVID-19
- Cohorting patients and HCP
- Maximizing use of telemedicine
- Facilities have provided HCP with required education and training, including having them demonstrate competency with donningexternal icon and doffing, for any PPE ensemble that is used to perform job responsibilities, such as provision of patient care